RT-CGM in Young Adults at Risk of DKA
Assessment of the Impact of Real-time Continuous Glucose Monitoring on Glycaemic Control in High-risk Adolescents and Young Adults With Insulin-treated Diabetes
Imperial College London
20 participants
Sep 3, 2020
INTERVENTIONAL
Conditions
Summary
Pilot study to evaluate the effect of real time continuous glucose monitoring (RT-CGM) on young-adults with insulin-treated diabetes, who are defined as high risk due to suboptimal HbA1c (blood glucose control) or a history of hospital admissions for high blood glucoses. Hypothesis: RT-CGM provided to young adults with suboptimal blood glucose control, has a beneficial impact on HbA1c and hospital admissions for high blood glucoses. We will use data from this pilot work to inform a larger powered study to address this knowledge gap.
Eligibility
Inclusion Criteria5
- Adolescents and young adults aged 18-25 years
- Insulin-treated diabetes \>12 months (on multiple daily injections or insulin pump therapy)
- HbA1c \> 75 mmol/mol (9%) or 1 or more DKA admissions in the last 12 months or 1 or more admissions with uncontrolled blood glucose levels in the last 12 months.
- Naïve to RT-CGM - except for short periods for use for diagnosis or monitoring purposes.
- Use of prior flash glucose monitoring is permittable
Exclusion Criteria7
- Chronic kidney disease eGFR \<30ml/min
- Pregnant or planning pregnancy
- Breastfeeding
- Have active malignancy or under investigation for malignancy
- Severe visual impairment
- Reduced manual dexterity
- Unable to participate due to other factors, as assessed by the Chief Investigator
Interventions
Realtime Continous Glucose Monitoring
Finger prick self monitoring of blood glucose
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04039763